GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » Return-on-Tangible-Asset

Epsilon Healthcare (ASX:EPN) Return-on-Tangible-Asset : -7.48% (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Epsilon Healthcare's annualized Net Income for the quarter that ended in Jun. 2023 was A$-1.43 Mil. Epsilon Healthcare's average total tangible assets for the quarter that ended in Jun. 2023 was A$19.16 Mil. Therefore, Epsilon Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 was -7.48%.

The historical rank and industry rank for Epsilon Healthcare's Return-on-Tangible-Asset or its related term are showing as below:

ASX:EPN' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -57.69   Med: -38.29   Max: -16.74
Current: -30.88

During the past 6 years, Epsilon Healthcare's highest Return-on-Tangible-Asset was -16.74%. The lowest was -57.69%. And the median was -38.29%.

ASX:EPN's Return-on-Tangible-Asset is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.685 vs ASX:EPN: -30.88

Epsilon Healthcare Return-on-Tangible-Asset Historical Data

The historical data trend for Epsilon Healthcare's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare Return-on-Tangible-Asset Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Return-on-Tangible-Asset
Get a 7-Day Free Trial -39.44 -43.53 -37.13 -32.48 -57.69

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.43 -38.83 -72.08 -52.42 -7.48

Competitive Comparison of Epsilon Healthcare's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epsilon Healthcare's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's Return-on-Tangible-Asset falls into.



Epsilon Healthcare Return-on-Tangible-Asset Calculation

Epsilon Healthcare's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2022 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-13.289/( (25.574+20.5)/ 2 )
=-13.289/23.037
=-57.69 %

Epsilon Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=-1.434/( (20.5+17.819)/ 2 )
=-1.434/19.1595
=-7.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2023) net income data.


Epsilon Healthcare  (ASX:EPN) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Epsilon Healthcare Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (ASX:EPN) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines